New scan could save cancer patients from months of useless drugs
NCT ID NCT04020978
First seen Mar 11, 2026 · Last updated May 26, 2026 · Updated 8 times
Summary
This study tested a new type of PET scan to see if it could detect whether targeted therapy for genitourinary cancer (like kidney cancer) is working within days or weeks, instead of months. Eleven patients were scanned before and shortly after starting treatment. The goal was to see if early changes in tumor blood flow could predict later tumor shrinkage, potentially sparing patients from costly, toxic treatments that aren't helping.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GENITOURINARY CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UC Davis Medical Center
Sacramento, California, 95817, United States
Conditions
Explore the condition pages connected to this study.